condition found
Source: |
Type: |
Beta-Amyloid (Aβ): In Alzheimer’s disease, Aβ peptides tend to misfold and aggregate into oligomers and fibrils. |
3440- | ALA,  |   | Protective effects of alpha lipoic acid (ALA) are mediated by hormetic mechanisms |
- | Review, | AD, | NA |
3447- | ALA,  |   | Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells |
- | in-vitro, | AD, | SH-SY5Y |
3545- | ALA,  |   | Potential therapeutic effects of alpha lipoic acid in memory disorders |
- | Review, | AD, | NA |
3271- | ALA,  |   | Decrypting the potential role of α-lipoic acid in Alzheimer's disease |
- | Review, | AD, | NA |
3269- | ALA,  |   | Sulfur-containing therapeutics in the treatment of Alzheimer’s disease |
- | NA, | AD, | NA |
3549- | ALA,  |   | Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia |
- | Review, | AD, | NA |
3546- | ALA,  |   | Cognitive and Mood Effect of Alpha-Lipoic Acid Supplementation in a Nonclinical Elder Sample: An Open-Label Pilot Study |
- | Study, | AD, | NA |
760- | Bor,  |   | Therapeutic Efficacy of Boric Acid Treatment on Brain Tissue and Cognitive Functions in Rats with Experimental Alzheimer’s Disease |
- | in-vivo, | AD, | NA |
2816- | CUR,  |   | NEUROPROTECTIVE EFFECTS OF CURCUMIN |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3576- | CUR,  |   | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
- | Review, | AD, | NA |
3575- | CUR,  |   | The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse |
- | in-vivo, | AD, | NA |
3574- | CUR,  |   | The effect of curcumin (turmeric) on Alzheimer's disease: An overview |
- | Review, | AD, | NA |
3232- | EGCG,  |   | (−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression |
- | in-vivo, | AD, | NA |
3237- | EGCG,  |   | (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression |
- | in-vivo, | AD, | NA |
2861- | FIS,  |   | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
- | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
2894- | HNK,  |   | Pharmacological features, health benefits and clinical implications of honokiol |
- | Review, | Var, | NA | - | Review, | AD, | NA |
2869- | HNK,  |   | Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's |
- | Review, | AD, | NA | - | Review, | Park, | NA |
2916- | LT,  |   | Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
3532- | Lyco,  |   | Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer’s disease |
- | in-vitro, | AD, | NA |
3489- | MFrot,  |   | Rotating magnetic field inhibits Aβ protein aggregation and alleviates cognitive impairment in Alzheimer's disease mice. |
- | in-vivo, | AD, | NA |
3488- | MFrot,  |   | Rotating magnetic field improves cognitive and memory impairments in APP/PS1 mice by activating autophagy and inhibiting the PI3K/AKT/mTOR signaling pathway |
- | in-vivo, | AD, | NA |
2963- | PL,  |   | Piperlongumine activates Sirtuin1 and improves cognitive function in a murine model of Alzheimer’s disease |
- | in-vitro, | AD, | HEK293 |
3343- | QC,  |   | Quercetin, a Flavonoid with Great Pharmacological Capacity |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Arthritis, | NA |
3380- | QC,  |   | Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases |
- | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
3374- | QC,  |   | Therapeutic effects of quercetin in oral cancer therapy: a systematic review of preclinical evidence focused on oxidative damage, apoptosis and anti-metastasis |
- | Review, | Oral, | NA | - | Review, | AD, | NA |
3336- | QC,  |   | Neuroprotective Effects of Quercetin in Alzheimer’s Disease |
- | Review, | AD, | NA |
3080- | RES,  |   | Resveratrol: A miraculous natural compound for diseases treatment |
- | Review, | Var, | NA |
3057- | RES,  |   | The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
3100- | RES,  |   | Neuroprotective effects of resveratrol in Alzheimer disease pathology |
- | Review, | AD, | NA |
3490- | RF,  |   | Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3461- | RF,  |   | Electromagnetic Field Stimulation Therapy for Alzheimer’s Disease |
- | Review, | AD, | NA |
3028- | RosA,  |   | Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer’s disease |
- | in-vitro, | AD, | HT22 | - | in-vivo, | NA, | NA |
3003- | RosA,  |   | Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
3321- | SIL,  |   | Silymarin (Milk thistle) |
- | Review, | AD, | NA |
3320- | SIL,  |   | Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action |
- | Review, | AD, | NA |
3319- | SIL,  |   | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3555- | TQ,  |   | Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta1-42 infused rat model |
- | in-vivo, | AD, | NA |
3556- | TQ,  |   | Thymoquinone alleviates the experimentally induced Alzheimer’s disease inflammation by modulation of TLRs signaling |
- | in-vivo, | AD, | NA |
3571- | TQ,  |   | The Role of Thymoquinone in Inflammatory Response in Chronic Diseases |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
3570- | TQ,  |   | Thymoquinone alleviates the experimentally induced Alzheimer's disease inflammation by modulation of TLRs signaling |
- | in-vivo, | AD, | NA |
3565- | TQ,  |   | Thymoquinone as a potential therapeutic for Alzheimer’s disease in transgenic Drosophila melanogaster model |
3564- | TQ,  |   | The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer's Disease-like Condition: Mechanistic Insights |
- | in-vivo, | AD, | NA |
3557- | TQ,  |   | Thymoquinone protects against lipopolysaccharides-induced neurodegeneration and Alzheimer-like model in mice. |
- | in-vivo, | AD, | NA |
3559- | TQ,  |   | Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease |
- | Review, | AD, | NA | - | Review, | Var, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1333 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid